Clinical significance of serum tenascin-c levels in epithelial ovarian cancer

Tumor Biology

Volumn 35, Issue 7, 2014, Pages 6777-6782

  Didem, Tastekin ^a   Faruk, Tas ^a   Senem, Karabulut ^a   Derya, Duranyildiz ^a   Murat, Serilmez ^a   Murat, Guveli ^a   Oznur, Kaynur ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ANKARA ONCOLOGY EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Epithelial ovarian cancer; Prognosis; Tenascin C

Indexed keywords

TENASCIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SOLID PHASE EXTRACTION;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS; TENASCIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84905053983     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1923-z     Document Type: Article

References (21)

1. Midwood KS, Hussenet T, Langlois B, Orend G. Advances in tenascin-C biology. Cell Mol Life Sci. 2011;68(19):3175-99.
2. Orend G, Chiquet-Ehrismann R. Tenascin-C induced signaling in cancer. Cancer Lett. 2006;244(2):143-63. (Pubitemid 44508708)
3. Oskarsson T, Acharyya S, Zhang XH, Vanharanta S, Tavazoie SF, Morris PG, et al. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med. 2011;17(7):867-74.
4. Midwood KS, Orend G. The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal. 2009;3(3-4):287-310.
5. Wilson KE, Langdon SP, Lessells AM, Miller WR. Expression of the extracellular matrix protein tenascin in malignant and benign ovarian tumours. Br J Cancer. 1996;74(7):999-1004. (Pubitemid 26333897)
6. Wilson KE, Bartlett JM, Miller EP, Smyth JF, Mullen P, Miller WR, et al. Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines. Br J Cancer. 1999;80(5-6):685-92. (Pubitemid 29209829)
7. Guttery DS, Shaw JA, Lloyd K, Pringle JH, Walker RA. Expression of tenascin-C and its isoforms in the breast. Cancer Metastasis Rev. 2010;29(4):595-606.
8. Tsunoda T, Inada H, Kalembeyi I, Imanaka-Yoshida K, Sakakibara M, Okada R, et al. Involvement of large tenascin-C splice variants in breast cancer progression. Am J Pathol. 2003;162(6):1857-67. (Pubitemid 36613044)
9. Takeda A, Otani Y, Iseki H, Takeuchi H, Aikawa K, Tabuchi S, et al. Clinical significance of large tenascin-C spliced variant as a potential biomarker for colorectal cancer. World J Surg. 2007;31(2):388-94. (Pubitemid 46183528)
10. Leins A, Riva P, Lindstedt R, Davidoff MS, Mehraein P, Weis S. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma. Cancer. 2003;98(11):2430-9. (Pubitemid 37466658)
11. Zámecník J, Chánová M, Tichý M, Kodet R. Distribution of the extracellular matrix glycoproteins in ependymomas - an immunohistochemical study with follow-up analysis. Neoplasma. 2004;51(3):214-22. (Pubitemid 38821502)
12. Iskaros BE, Sison CP, Hajdu SI. Tenascin patterns of expression in duct carcinoma in situ of the breast. Ann Clin Lab Sci. 2000;30(3):266-71. (Pubitemid 30620801)
13. Doi D, Araki T, Asano G. Immunohistochemical localization of tenascin, estrogen receptor and transforming growth factor-beta 1 in human endometrial carcinoma. Gynecol Obstet Invest. 1996;41(1):61-6. (Pubitemid 26021656)
14. Sis B, Saǧol O, Küpelioǧlu A, Sokmen S, Terzi C, Fuzun M, et al. Prognostic significance of matrix metalloproteinase-2, cathepsin D, and tenascin-C expression in colorectal carcinoma. Pathol Res Pract. 2004;200(5):379-87. (Pubitemid 38950421)
15. Emoto K, Yamada Y, Sawada H, Fujimoto H, Ueno M, Takayama T, et al. Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma. Cancer. 2001;92(6):1419-26. (Pubitemid 32947825)
16. Parekh K, Ramachandran S, Cooper J, Bigner D, Patterson A, Mohanakumar T. Tenascin-C, over expressed in lung cancer down regulates effector functions of tumor infiltrating lymphocytes. Lung Cancer. 2005;47(1):17-29. (Pubitemid 39643238)
17. Ishiwata T, Takahashi K, Shimanuki Y, Ohashi R, Cui R, Takahashi F, et al. Serum tenascin-C as a potential predictive marker of angiogenesis in non-small cell lung cancer. Anticancer Res. 2005;25(1B):489-95. (Pubitemid 40470055)
18. Burchardt ER, Hein R, Bosserhoff AK. Laminin, hyaluronan, tenascin-C and type VI collagen levels in sera from patients with malignant melanoma. Clin Exp Dermatol. 2003;28(5):515-20. (Pubitemid 37100556)
19. Pauli C, Stieber P, Schmitt UM, Andratschke M, Hoffmann K, Wollenberg B. The significance of Tenascin-C serum level as tumor marker in squamous cell carcinoma of the head and neck. Anticancer Res. 2002;22(5):3093-7.
20. Riedl S, Bodenmüller H, Hinz U, Holle R, Möller P, Schlag P, et al. Significance of tenascin serum level as tumor marker in primary colorectal carcinoma. Int J Cancer. 1995;64(1):65-9.
21. Degen M, Brellier F, Schenk S, Driscoll R, Zaman K, Stupp R, et al. Tenascin-W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patients. Int J Cancer. 2008;122(11):2454-61. (Pubitemid 351590477)